Msosa, Takondwa Charles https://orcid.org/0000-0002-4375-5572
Swai, Iraseni
Sumari-de Boer, Marion
Ngowi, Kennedy
F. Rinke de Wit, Tobias
Aarnoutse, Rob
Nliwasa, Marriott
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (TMA2818)
Helse Nord Tuberculosis Initiative
Article History
Received: 18 May 2023
Accepted: 5 July 2023
First Online: 15 August 2023
Declarations
:
: Study staff will ensure that study participants fully understand study procedures and consequences and not feel pressured or forced to give consent. Therefore, procedures as described in the Declaration of Helsinki [] and the Oviedo Bioethics Convention [] will be followed. Additionally, it will be ensured that all study procedures and processes are conducted according to Malawian and all applicable international laws.The trial protocol has been approved by the College of Medicine Research Ethics Committee (COMREC), approval number P.11/22/3877. Participants will consent for any future ancillary studies that are not described in this protocol upon further ethical approval from COMREC.
: No consent will be sought for publication.
: The authors declare that they have no competing interests.